The RS4939827 polymorphism in the SMAD7 GENE and its association with Mediterranean diet in colorectal carcinogenesis by Alonso Molero, Jessica et al.
RESEARCH ARTICLE Open Access
The RS4939827 polymorphism in the
SMAD7 GENE and its association with
Mediterranean diet in colorectal
carcinogenesis
Jéssica Alonso-Molero1, Carmen González-Donquiles2* , Camilo Palazuelos3, Tania Fernández-Villa1, Elena Ramos1,
Marina Pollán4,5, Nuria Aragonés4,5, Javier Llorca3,4, M. Henar Alonso4,6,7,8, Adonina Tardón4,9, Pilar Amiano4,10,
José Juan Jiménez Moleon4,11, Rosana Peiró Pérez4,12, Rocío Capelo13, Antonio J. Molina1, Inés Gómez Acebo3,4,
Marcela Guevara10, Beatriz Pérez Gómez4,5,14, Virginia Lope4,5, José María Huerta4,15,
Gemma Castaño-Vinyals4,16,17,18, Manolis Kogevinas4,16,17,18,19, Victor Moreno4,6,7,8† and Vicente Martín4,20†
Abstract
Background: The objective of our investigation is to study the relationship between the rs4939827 SNP in the
SMAD7 gene, Mediterranean diet pattern and the risk of colorectal cancer.
Methods: We examined 1087 cases of colorectal cancer and 2409 population controls with available DNA samples
from the MCC-Spain study, 2008–2012. Descriptive statistical analyses, and multivariate logistic mixed models were
performed. The potential synergistic effect of rs4939827 and the Mediterranean diet pattern was evaluated with
logistic regression in different strata of of adherence to the Mediterranean diet and the genotype.
Results: High adherence to Mediterrenean diet was statistically significantly associated with colorectal cancer risk. A
decreased risk for CRC cancer was observed for the CC compared to the TT genotype (OR = 0.65 and 95% CI = 0.51–0.
81) of the rs4939827 SNP Also, we could show an association between the Mediterranean diet pattern (protective
factor) and rs4939827. Although the decreased risk for the CC genotype was slightly more pronounced in subjects with
high adherence to Mediterrenean diet, there was no statistically significant synergistic effect between genotype CC
and adherence to the Mediterranean dietary pattern factors.
Conclusion: The SMAD7 gene and specifically the allele C could be protective for colorectal cancer. An independent
protective association was also observed between high adherence Mediterranean diet pattern and CRC risk. Findings
form this study indicate that high adherence to Mediterranean diet pattern has a protective role for CRC cancer
probably involving the Tumor Growth Factor- β pathway in this cancer.
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Background
Colorectal cancer (CRC) has the third highest inci-
dence in men, and the second highest in women
worldwide [1]. This cancer has an increasing inci-
dence in developing countries [2] probably due to the
increasing prevalence of environmental factors that
contribute to the development of CRC, for instance,
dietary pattern and physical activity [3]. On the other
hand, mortality levels are decreasing in countries with
specialized care and better screening services [4].
Gene-Environment (GxE) interactions may play an es-
sential role in increasing the susceptibility to develop-
ing colorectal cancer [3]. Among these factors, it is
important to pay attention to the Mediterranean Diet
Pattern adherence, since lower adherence to this pattern
is more common as a direct consequence of the general
westernization of the lifestyle’s population [5–7]. Asses-
sing the adherence to a Mediterranean dietary pattern is
one of the particularly interesting approaches which may
help to understand the relationship between diet and CRC
[8]. However, the effect of this pattern over health depends
on many individual aspects, involving genetic factors
and polymorphisms. The lack of knowledge about the
interactions between diet-polymorphism is a huge prob-
lem for the public health [9].
Earlier studies show a possible relationship between
the diet pattern and the rs4939827 SNP in SMAD7
(SMAD family member 7), which has been associated
to CRC previously. The SMAD7 gene acts as a Trans-
forming Growth Factor Beta (TGF-β) family inhibitor
by blocking the pathway signaling (Fig. 1) [10]. TGF-β
encodes for a cytokines family, which are multifunc-
tional peptides that control some process like cell
proliferation. In this way, when TGF-β is inhibited by
the interaction with SMAD7, cell proliferation is
promoted and this could lead to the development of
cancer. Another key gene in the undirected regulation
of SMAD7 expression is the gene Ski (SKI proto-
oncogene), which acts by blocking the TGF-β target
genes, as SMAD7 [11, 12].
The interaction between the Mediterranean diet and
the SMAD7 gene may be due to the action of other
genes that are involved in the TGF-β pathway, in par-
ticular SMAD3 (SMAD family member 3), which is
inhibited by the first one [13]. This pattern of diet is
characterized by high fiber contents and before a fer-
mentative process Na-butyrate is produced. This com-
pound interacts with SAMD3, highlighting the signaling
of this pathway [11]. In this way, we can check that the
relationship between the dietary pattern and SMAD7 ex-
pression is real.
The goal of this article is to investigate the relationship
between the rs4939827 SNP, the Mediterranean Diet
Pattern and the risk of CRC.
Method
Study population
MCC-Spain is a multicentric case-control study with
population controls aiming to evaluate the influence of
environmental exposures and their interaction with gen-
etic factors in common tumors in Spain (prostate,
breast, colorectal, gastroesophageal and chronic lympho-
cytic leukemia). Between September 2008 and December
2013, subjects between 20 and 85 years of age (matched
by 5-year age interval) with histologically-confirmed
newly-diagnosed colon or rectum cancer (ICD-10: C18,
C19, C20, D01.0, D01.1, D01.2) were recruited in 23
Spanish hospitals from 12 Spanish provinces. Simultan-
eously, population-based controls frequency-matched to
cases, by age, sex and region with the join distribution of
the tumors included in MCC were randomly selected
from primary care centers within hospitals’ catchment
areas. All participants signed an informed consent. Ap-
proval for the study was obtained from the ethical review
boards of all recruiting centers. Additional information
regarding the study design is provided elsewhere [14].
Fig. 1 Signaling pathway TGFβ-SMAD
Alonso-Molero et al. BMC Medical Genetics  (2017) 18:122 Page 2 of 9
In our study, 3496 individuals were included from this
MCC-Spain study. For this analysis, 1087 cases of
colorectal cancer and 2409 controls were involved with
available DNA samples for genetic analysis.
Lifestyle information
A computerized epidemiological questionnaire includ-
ing self-reported socio-demographic and anthropomet-
ric data, family history of cancer, environmental
exposures, use of selected drugs, reproductive history
and current and past lifestyle behaviors (including
leisure time physical activity and sedentary lifestyle)
was administered by trained personnel in a face-to-
face interview at enrolment. Waist and hip circumfer-
ences were measured by the interviewer [14]. Subjects
were provided a previously validated semi-quantitative
Spanish Food Frequency Questionnaire (FFQ) [15]
which was modified to include regional products. The
FFQ included 140 food items, and assessed usual
dietary intake during the previous year. The FFQ in-
cluded the specific cooking methods for meat and
some pictures to establish how thoroughly-cooked
participants prefer it. The FFQ was self-administered
and returned by mail or filled out face to face (global
response rate 88%). Frequency data was used to de-
rive amount (g/day, g/1000 kcal) of each of the indi-
vidual food types and summary variables. The food
composition table has been a compiled table from the
Centre for Higher Studies in Nutrition and Dietetics
(CESNID) and other specific sources [16]. Cross-
check questions on food groups intakes were used to
adjust the frequency of foods eaten and reduce misre-
porting of food groups with large numbers of items
[17, 18]. Data from this questionnaire was used to
obtain a score in order to know the adherence to the
Mediterranean diet by Sofi F [19]. Sofi F. et al. have
computed the adherence to this type of diet taking
into account 9 groups of foods (vegetables, legumes,
meat, fish, integral cereals, fruit, dairy products, alco-
hol, olive oil) [19]. The range of this score goes from
zero to eighteen points. From that score, we create
subsets based on individuals with low (if the score is <9),
medium (from 9 to 11 points) or high (if the score is
higher than eleven points) adherence to this kind of diet
[12]. Since the Mediterranean diet has a high fiber content
and the SMAD7 gene can interact with it, an analysis of
this factor was considered essential.
For the variable of physical activity, the last 10 years
were taken into account. This parameter also includes
recreational physical activity. The assessed parameter
was METs, a measured unit of metabolism. The re-
sponses obtained allowed us to create four subpopula-
tions: sedentary, low physical activity, average physical
activity and intense physical activity.
Samples processing
Peripheral blood (27 ml) was drawn from participants,
which were aliquoted in whole blood, plasma, cellular
fraction for DNA extraction, and serum and stored at
−80 °C. Saliva was collected for subjects refusing to
donate blood with the Oragene® DNA Kit and stored at
room temperature until DNA extraction. We collected
biological samples for DNA extraction for participants
with interview, as well as toenail and hair samples. In 4
centers (Madrid, Cantabria, Asturias and Huelva) cases
and controls also donated urine samples (60 ml) that
were aliquoted and frozen at −80 °C. Fresh tumor biop-
sies or paraffin embedded samples are available in all
participating hospitals. Standardized basic clinical and
pathological information on the diagnosis and treatment
of tumors was collected from hospital records by using a
predefined format.
Genetic analyses were carried out within MCC-Spain
and also through participation in international consor-
tia. The InfiniumHumanExomeBeadChip from Illumina
was used to genotype >200,000 coding markers plus
6000 additional custom variants on the pathways of
interest [14].
SNP selection
After a literature search, different SNPs that were associ-
ated with CCR were selected. These SNPs were proc-
essed with the PLINK software in order to verify that
they had been collected in the database of the MCC-
Spain. This file contains the basic data needed for
statistical analysis (cases and controls, SNPs, and the
identifier of each individual). Finally, after an ad-hoc
evaluation of the polymorphisms, rs4939827 was
selected and we performed the statistical analyses
described in the following section because only this SNP
was considered relevant in its relation with colorectal
cancer (see Additional file 1: Table S1).
Statistical methods.
First, a descriptive statistical analysis was performed to
determine the characteristics of our study population.
For age, mean and standard deviation were calculated.
For the rest of variables, we calculate frequencies of
cases and controls using STATA. Table 1 show variables
used in analysis and how they were classified.
Then multivariate logistic mixed models, including the
study region as a random effect term, were performed to
evaluate the association between genotypes of selected
polymorphisms and the risk of CRC. The same analysis
was made in order to show the association of the com-
ponent of the Mediterranean diet with the colorectal
cancer. Adjusted odds ratios and confidence intervals at
95% were calculated by reference to the homozygous
genotype of the most common allele (T allele). The
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minimally adjusted odds ratio was calculated by adjust-
ing by sex, age and educational background. The ad-
justed odds ratios were calculated taking into account
the variables mentioned before and BMI, total energy in-
take, family history first degree, race and METS.
Finally, linear regression was used for associations be-
tween polymorphisms and the study variables. For this,
the online software used was SNPstats, by the log-
additive model mainly, although we also observed the
results of other models (dominant, codominant, reces-
sive and overdominant) [20]. By using STATA, the
rs4939827 SNP association with the Mediterranean diet
pattern was evaluated with logistic regression. For that,
we stratified the variable of adherence to the Mediterra-
nean diet and the genotype was also taken into account.
Results
The initial study population consists of 6090 individ-
uals, distributed into 2140 cases and 3950 controls.
Among them, 3496 had both genetic information and
the dietary pattern available, the algorithm of missing
data can be seen in Fig. 2. Table 1 shows the main
characteristics of those individuals which the analysis
was performed with. Analyzing the missing data, it
has been observed that only men have significant
differences (in both case and control groups). The
rest of variables do not show significant differences
(Data not shown).
Table 1 Descriptive analysis results. Characteristics of cases and controls
CONTROLS CASES p-values
N % N %
2409 1087 –
Age (Mean/SD) 63.13 11.5 66.64 10.4 –
Sex Men 1300 54 708 65.1 <0.0001
Women 1109 46 379 34.9
First Degree Family History No 2081 90.6 855 82.1 <0.0001
Yes 216 9.4 186 17.9
Cultural level Less than primary school 409 17 288 26.5 <0.0001
Primary school 803 33.3 458 42.1
Secundary school 698 29 221 20.3
University 499 20.7 120 11
BMI Normal weight 759 31.5 259 23.8 <0.0001
Less than normal weight 23 1 13 1.2
Overweight 873 36.2 399 36.7
Obesity 754 31.3 416 38.3
Total energy (Kcal/Day) Low 795 33 296 27.2 <0.0001
Medium 794 33 320 29.4
High 820 34 471 43.3
METS Sedentarism 855 35.5 468 43.1 <0.0001
Low physical activity 385 16 134 12.3
Moderate physical activity 313 13 109 10
High physical activity 856 35.5 376 34.6
N Number, BMI Body Mass Index, METS Metabolic Equivalent of Task. The cut point for category of total energy are <1586.3 Kcal/day, ≥ 1586.3 Kcal/day
& < 2046.4 Kcal/day and ≤2046.4 for low, medium and high level respectively.For the physical activity, the cut points are 0 when the there is no physical activity,
< 8 METS*hours/week for low physical activity, ≥ 8 and < 16 METS*hours/week for moderated physical activity and >16 METS*hours/week for high physical
activity (according to American College of Sport Medicine)
Fig. 2 Algorithm for cases and controls for this study, selected from
the population which participated in the project
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Descriptive analysis
In this study 3496 participants have been included, 1087
cases (65.1% males; 34.9% females) and 2407 controls
(54% males; 46% females). The characteristics of the
individuals of this study are described in Table 1. Data
belong to a multi case-control study and matches were
performed by frequencies in all types of tumors (colorec-
tal, mama, prostate, leukemia, stomach), so it can be the
reason for the mismatch between the sex distribution
between affected cases and frequency-matched controls.
In the study population, the average age is 66.6 (±10.4)
in cases and 63.1 (±11.5) in controls. Physical activity
habits show a sedentary population, with 43.0% in cases
and 35.5% in controls who do not practice physical
activity. BMI shows that only 23.8% in cases and 31.5%
in controls have an adequate weight. Most of the popu-
lation suffers from obesity or being overweight.
Mediterranean diet pattern and components analysis
The components of the Mediterranean diet pattern by
case-control status are shown in Table 2. We observe
that there are significant differences in alcohol intake in
the last 10 years between cases and controls, however
we have not got any clear evidence that alcohol intake in
the Mediterranean diet is associated with CRC. The op-
posite case can be found in vegetables and legumes,
where a high intake of them may be protective against
colorectal cancer. On the other hand, meat and dairy
Table 2 Association between intake levels of food components in the Mediterranean diet anc case (affection) status. The cut points
are based on the score criteria for Sofi’s Mediterranean diet pattern
CONTROLS CASES OR minimally adjusted CI (95%) OR adjusted CI (95%)
N % N %
2409 1087
Alcohol Moderate intake (12 g/day-24 g/day) 612 25.4 386 35.5 1 1 1 1
Hight intake (>24 g/day) 1471 61.1 537 49.4 1.17 0.92–1.49 0.76 0.60–0.97
Low intake (<12 g/day) 326 13.5 164 15.1 0.77 0.61–0.98 1.04 0.81–1.33
Vegetables Low intake (<100 g/day) 563 23.4 306 28.2 1 1 1 1
Moderate intake (100 g/day-250 g/day) 1378 57.2 624 57.4 0.82 0.68–0.98 0.85 0.70–1.03
Hig/dayh intake (>250) 468 19.4 157 14.4 0.54 0.42–0.70 0.55 0.42–0.72
Legumes Low intake (<70 g/day) 1561 64.8 670 61.6 1 1 1 1
Moderate intake (70 g/day-140 g/day) 383 15.9 177 16.3 0.94 0.76–1.16 0.97 0.77–1.21
Hig/dayh intake (>140 g/day) 465 19.3 240 22.1 0.75 0.60–0.92 0.77 0.61–0.96
Meat Low intake (<80 g/day) 185 7.7 152 14.0 1 1 1 1
Moderate intake (80 g/day-120 g/day) 442 18.3 236 21.7 1.4 1.15–1.70 1.29 1.05–1.60
Hig/dayh intake (>120 g/day) 1782 74.0 699 64.3 1.98 1.54–2.55 1.74 1.32–2.30
Dairy products Low intake (<180 g/day) 1541 64.0 693 63.8 1 1 1 1
Moderate intake (180 g/day-270 g/day) 557 23.1 250 23.0 0.95 0.74–1.23 0.97 0.74–1.28
Hig/dayh intake (>270 g/day) 311 12.9 144 13.2 1.02 0.82–1.29 1.01 0.79–1.30
Fruits Low intake (<150 g/day) 0 0 0 0 1 1 1 1
Moderate intake (150 g/day-300 g/day) 0 0 0 0 0 0 0 0
Hig/dayh intake (>300 g/day) 2409 100 1087 100 omitted omitted
Cereals Low intake (<130 g/day) 2327 96.6 1047 96.3 1 1 1 1
Moderate intake (130 g/day-195 g/day) 71 2.9 32 2.9 0.97 0.62–1.51 1.08 0.68–1.74
Hig/dayh intake (>195 g/day) 11 0.5 8 0.7 1.57 0.62–4.01 1.42 0.50–4.02
Fish Low intake (<100 g/day) 169 7.0 91 8.4 1 1 1 1
Moderate intake (100 g/day-250 g/day) 663 27.5 304 28.0 0.91 0.67–1.22 0.9 0.65–1.25
Hig/dayh intake (>250 g/day) 1577 65.5 692 63.7 0.82 0.62–1.09 0.84 0.62–1.16
Olive oil Low intake (<0.1 g/day) 115 10.6 245 10.2 1 1 1 1
Moderate intake (0.1 g/day-0.99 g/day) 206 19.0 513 21.3 0.88 0.72–1.07 0.85 0.69–1.05
Hig/dayh intake (>1 g/day) 766 70.5 1651 68.5 0.85 0.67–1.10 0.91 0.70–1.21
The minimally adjusted odds ratio (OR) was calculated adjusting by sex, age (as continuous variable) and educational level from a multivariate logistic mixed
model.Area was used as random variable. The adjusted odds ratios were calculating taking into account the variables mentioned before and BMI, total energy
intake, family history fist degree, race and METS. (N: Number; CI: Confidence Interval). Cut-offs are based on score criteria of Sofi’s Mediterranean Pattern [19]
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products are risk factors when they are consumed in
high quantities. Other components (integral cereals, fish
and olive oil) do not show significant differences. Fruit
cannot be analyzed because there are not enough sub-
jects (Table 2).
Taking into account the adherence to the Mediterranean
dietary pattern, 68.6% of cases and in 75.3% of controls
have a high or medium adherence to the Mediterranean
dietary pattern. All these variables show significant differ-
ences between cases and controls (Table 3).
Associations of rs4939827 with CRC and other factors
The rs4939827 SNP was statistically significantly associ-
ated with colorectal cancer according to several models.
The most important result is referred to the Log-
Additive model (p-value = 1.00E-04). The association of
this polymorphism with CRC can also be observed in
other models in a significant way: codominant model (p-
value = 2e-04); dominant model (p-value = 6e-04);
recessive model (p-value = 8e-04). The analysis of asso-
ciation of this polymorphism with risk factors is also
shown in the summary table.
rs4939827 associations with risk factors of this study
After analyzing the association between rs4939827 and
risk factors, statistically significant results can be
observed in the case of the degree of adherence to the
Mediterranean dietary pattern. Other factors assessed
did not show a significant association with the SNP (data
not shown). We conducted an analysis for rs4939827
with an interaction term to evaluate the independent
main effect of the Mediterranean diet and main effect of
the protective rs4939827 allele (see Additional file 2:
Table S2). However, none of the results provide a signifi-
cant p-value although the overdominant model is close
to p-value = 0.05 (p-value = 0.07), determining that C
allele it the dominant one.
The CC genotype (16.1% in cases and 20.5% in controls)
seems to be protective compared to the TT (35.6% in
cases and 30.3% in controls) genotype (ORaTTvsCT = 0.82
IC (95%) = 0.69–0.98; ORa TTvsCC = 0.65 IC
(95%) = 0.51–0.81). When we check the association with
adherence pattern to the Mediterranean diet (only statisti-
cally significant association), it can be observed that high
adherence is a protective factor (Fig. 3 and Table 3). How-
ever, we could not see a synergistic effect between both
genotype CC and adherence to the Mediterranean dietary
pattern factors.
Discussion
SMAD7 is a target gene of the signaling pathway TGFβ-
SMAD. For the TGFβ expression, it must be joined with
its receptor type II. This binding stimulates the receptor
type I, which binds to the above complex and, the
complete assembly, is able to regulate the formation and
activation (by phosphorylation) of the heterodimeric
complex SMAD2/3. After the activation, this complex
joins SMAD4 (SMAD family member 4) protein, which
helps the complex translocation to the nucleus. In this
organelle, the activation of the expression of target genes
of TGFβ occurs, including the SMAD7 gene and other
Table 3 Association between SNP rs4939827 and the
Mediterranean dietary pattern adherence in relation with
colorectal cancer taking into account the genotype
Cases Controls Adjusted OR
n % n % OR CI 95%
Low 341 31.4 594 24.7 1 –
TT 110 32.2 171 28.8 1 –
CT 169 49.6 302 50.8 0.83 0.59–1.17
CC 62 18.2 121 20.4 0.70 0.44–1.08
Medium 431 39.7 1010 41.9 0.85 0.70–1.03
TT 154 35.7 316 31.29 1 –
CT 211 49 478 47.2 0.87 0.65–1.15
CC 66 15.3 216 21.38 0.64 0.44–0.93
High 315 29.0 805 33.4 0.64 0.51–0.79
TT 123 39.1 242 30.1 1 –
CT 144 45.7 405 50.3 0.75 0.55–1.02
CC 48 15.2 158 19.6 0.63 0.42–0.96
CT vs TT: Adjusted Odd Ratio (OR) = 0.82 and 95% Confidence
Interval (CI) = 0.69–0.98
CC vs TT: OR = 0.65 and 95% CI = 0.51–0.81
The adjusted odds ratios (OR) was calculating taking into account the variables
sex, age, educational level, BMI, total energy intake, family history fist degree,
METS. Area was used as random variable (N: Number; CI: Confidence Interval)
Fig. 3 Association between SNP rs4939827 and the Mediterranean
dietary pattern adherence in relation with colorectal cancer taking into
account the genotype. Reference: TT genotype. Vertical axis: Adjusted
Odd Ratio (The adjusted odds ratios (OR) was calculating taking into
account the variables sex, age, socioeconomic level, BMI, total energy
intake, family history fist degree, METS and area was used as random
variable). Abscissa axis: Mediterranean Diet Pattern Adherence
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genes responsible for proliferation inhibition and cell
division. This happens when the SKI protein is not in
the nucleus, which is capable of binding with the hetero-
trimeric complex and inhibit its function, inhibiting the
expression of the SMAD7 gene in this way (Fig. 1) [6, 7].
In this study of 1087 cases of CRC and 2409 controls,
the rs4939827 SNP with the CC genotype was associated
with a reduction of the risk for colorectal cancer. This
may be due to SMAD7 participation modulating the
TGFβ pathway. SMAD7 protein is capable of binding
with TGFβ, causing its ubiquitination and destruction.
In this way, the action of TGFβ is inhibited and cell pro-
liferation can occur. To clarify the role of SMAD7 in cell
growth in the CRC, Halder et al. [21], overexpressed this
gene. This fact produces a higher cell growth than in
normal conditions (21). At the same time, it has been
observed that inhibition of SMAD7 with a specific oligo-
nucleotide reduces cell growth in CRC [22]. This data
leads to the hypothesis that rs4939827 with genotype
CC is a protective genotype because the correct expres-
sion of the SMAD7 gene is inhibited, preventing cell
proliferation and reducing the susceptibility to colorectal
cancer.
This hypothesis is supported by B. Zhang et al. (2014)
[23] who share the idea that the gene variant rs4939827
may be associated with an increase of CRC survivorship
[23]. Similarly, Slattery M. et al. (2010) [24] also agree with
our results as they show that the CC genotype is inversely
associated with the risk of colon cancer. Thus, they con-
clude that individuals containing the homozygous reces-
sive gene variant rs4939827 show a reduced risk of colon
cancer by a 27% [24]. Thompson C.L. et al. (2009) [25]
performed an analysis of the SNP taking into account the
dominant model, stratifying the population according to
gender. They noticed that women with the C allele were
associated with a decreased risk of CRC. In contrast, they
did not obtain significant results in men [25].
The CC genotype of this polymorphism was also asso-
ciated with survival of other cancers. For example, ac-
cording to Geng, T.T. et al. (2015) [26], the dominant
model showed that the rs4939827 polymorphism was
significantly associated with a decreased risk of esopha-
geal cancer by 0.67 fold due to a possible inhibition of
the SMAD7 gene [26].
The T allele must also be taken into account. Although
T allele does not show a significant risk in our results,
many authors support the idea by Jung KJ et al. (2015)
[27], which defended the hypothesis that the T allele of
this SNP was a risk factor for colorectal cancer and rec-
tal cancer [27]. Furthermore, according to analysis made
by Baert-Desurmont S. et al. (2015) [28] an increased
risk is observed depending on the number of T alleles
present in genotype [28]. Ho J. W. et al. (2011) [29] ana-
lyzed the risk of TC heterozygous and TT homozygous
genotypes. They identified both as risk genotypes, but
only the homozygous genotype showed a significant re-
sult [29]. Tenesa A. et al. (2008) [30], after taking into
account the location of the tumor to perform the ana-
lysis, noted that the T allele is a risk factor mainly for
rectal cancer and not for the colon cancer [30]. In our
results, we cannot verify that information, since we did
not identify the T allele as a risk allele, only the C allele
could be identified as a protective allele. Tenesa A. et al.
(2010) [31] also associated the T allele of the rs4939827
SNP with an increase of mortality [31]. Passarelli M.N.
et al. (2011) [32] found that SMAD7 variants that inhibit
TGFβ completely may reduce its tumor suppressor ac-
tivity (resulting in an increased risk), but can also reduce
their ability to promote their metastatic promoter activ-
ity (resulting in a slower progression of the tumor and
improved survival) [32]. Finally, Yao et al. (2015) [33]
support that the T allele increases the risk of CRC in
Caucasian population [33].
If we analyze the SNP association with diet, our results
are statistically significant. However, few authors refer to
the association of this factor with the rs4939827 poly-
morphism. As it is mentioned before, association with
the diet is due to the TGFβ signaling pathway genes that
interact with SMAD7. There is evidence that this associ-
ation may be due to the ingestion of high amounts of
fiber in the Mediterranean diet. Vegetables and fruit, for
example, are highly fermentable fiber sources, while
products such as wheat bran are low fermentable. The
difference is the amount of short-chain fatty acid formed
after fermentation of the fiber by the colon’s bacteria in
this organ, as described by Nguyen K.A. et al. (2006)
[11]. So, food containing fermentable fiber (fruit and
vegetables) will produce higher amount of fatty acids
than that containing short chain poorly fermentable
fiber. Therefore, there is a positive relationship between
the consumption of large amounts of fiber and a lower
risk of colon cancer. This may be due to the fact that
the Na-butyrate (Na-B, the main product of the fermen-
tation of fiber) is able to induce cell cycle arrest, cellular
differentiation and, even, apoptosis. It seems that the
Na-B is capable of inducing, selectively, Smad3 phos-
phorylation, so pathway activity of TGF-β is enhanced
[6, 7]. Despite this, we have not found a statistically sig-
nificant interaction in our results. It may be due it has
not got enough statistical power or the actual interaction
is carried out with SMAD3. This produces that TGF-β is
not ever ubiquitined and degraded, so cyclins jogging
cell proliferation (p15, p21 and p27) are expressed [34].
Besides, one of SMAD7 functions is to produce cell cycle
arrest in G1 phase. However, because of this mutation,
this activity cannot be carried out by this process. Na-B
intake helps this action be covered, further minimizing
the risk of uncontrolled cell proliferation.
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One limitation in this work is that genotype x diet ef-
fect could be due to fiber intake rather than adherence
to the Mediterranean diet, although both concepts are
related.
Conclusions
There is an important role of SMAD7 gene in colorectal
cancer as the allele C is protective against this disease.
Also, we can see a protective association between
rs4939827 SNP and high adherence to the Mediterranean
diet pattern and we suppose that high adherence to
Mediterranean diet pattern probably has a protective role.
So they may participate together in the TGFβ pathway in
colorectal cancer.
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